MRC TECHNOLOGY

NW7 1AD (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£577,853

Jan 13 - Dec 15

A therapeutic anti-IL16 antibody for the treatment of Ischaemic Reperfusion Injury

Innovate UK award to MRC TECHNOLOGY and Joanne Bayliss

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}